Page last updated: 2024-08-21

alpha-aminopyridine and Angelman Syndrome

alpha-aminopyridine has been researched along with Angelman Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baudry, M; Bi, X; Hao, X; Johe, K; Liu, Y; Sun, J; Wang, Y	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Angelman Syndrome

Article	Year
Enhancement of synaptic plasticity and reversal of impairments in motor and cognitive functions in a mouse model of Angelman Syndrome by a small neurogenic molecule, NSI-189. Neuropharmacology, 2019, Volume: 144 Topics: Aminopyridines; Angelman Syndrome; Animals; Central Nervous System Agents; Cognition; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Long-Term Potentiation; Male; Mice, Transgenic; Motor Activity; Piperazines; Tissue Culture Techniques	2019

Article

Year

Enhancement of synaptic plasticity and reversal of impairments in motor and cognitive functions in a mouse model of Angelman Syndrome by a small neurogenic molecule, NSI-189.

Neuropharmacology, 2019, Volume: 144

Topics: Aminopyridines; Angelman Syndrome; Animals; Central Nervous System Agents; Cognition; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Long-Term Potentiation; Male; Mice, Transgenic; Motor Activity; Piperazines; Tissue Culture Techniques

2019